Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 11/30/2009
More...
|
Cephalon, Inc. (CEPH) Delays Ception Deal After Mixed Drug Data 11/24/2009
More...
|
Novartis International AG (NVS) Says EU Approves Inflammatory Disease Drug 10/28/2009
More...
|
XOMA (US) LLC (XOMA) Presents Data At American Diabetes Association Demonstrating Improvement in Diabetes and Inflammatory Measures in Animal Model With XOMA 052 6/9/2009
More...
|
High-Dose Statin Rapidly Reduces Inflammation, Cambridge University Study 4/30/2009
More...
|
Vitamin E Shows Possible Promise In Easing Chronic Inflammation, University of Illinois Study 12/5/2008
More...
|
Karo Bio AB and Wyeth Pharmaceuticals (New Jersey) (WYE) Collaboration - Targets Inflammation 11/20/2008
More...
|
ProtoKinetix Inc. (PKTX.OB) Receives Independent Confirmation of AAGP Anti-Inflammatory Action 11/10/2008
More...
|
BioElectronics Corporation Announces Italian Over-the-Counter Approval From Ministry of Health for ActiPatch(TM) 10/28/2008
More...
|
Inflammation, Coagulation Tied to Non-AIDS Deaths in HIV Cases, International Network for Strategic Initiatives in Global HIV Trials Study 10/22/2008
More...
|
Lev Pharmaceuticals, Inc.'s Cinryze(TM) Receives FDA Approval for Prophylaxis Against Hereditary Angioedema Attack 10/13/2008
More...
|
Painkillers Cut Breast Cancer, University of British Columbia And University Of Santiago De Compostela Study; Largest Review Of Its Kind Associates Anti-inflammatory Drugs With Reduced Breast Cancer Risk 10/8/2008
More...
|
Novel Mechanism To Reduce Nervous System Inflammation Identified, Georgetown University Medical Center Study 9/29/2008
More...
|
New Drug Target For Inflammatory Disease Discovered by University of California, Davis (UCD) Researchers 9/25/2008
More...
|
Arana Therapeutics Updates Inflammatory Pipeline Milestones 9/22/2008
More...
|
ProtAffin AG Granted Orphan Medicinal Product Designation by European Medicines Evaluation Agency for Lead Anti-Inflammatory Product 7/18/2008
More...
|
Potential Role Of Fish-based Fatty Acids In Resolving, Preventing Asthma, Harvard Medical School Study 6/25/2008
More...
|
Chromium Ingredient May Have Diabetes Benefits: Data Presented at American Diabetes Association Scientific Session 6/12/2008
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Presents Preclinical Data of Toll-Like Receptor Antagonists in Models of Lung Inflammation and Psoriasis 6/9/2008
More...
|
GlaxoSmithKline (GSK) and Immune Disease Institute In $25M Partnership 6/4/2008
More...
|
BioElectronics Corporation Announces Profitability Breakeven and Additional Clinical Trials 6/4/2008
More...
|
Link Between Inflammation, Cancer Confirmed, Massachusetts Institute of Technology (MIT) Study 6/3/2008
More...
|
Clarification on Press Release Issued Earlier Today: Targeted Genetics Corporation (TGEN) Confirms Positive, Interim Phase 1/2 Study Findings; Trial Demonstrates Safety and Preliminary Efficacy and Supports Further Clinical Development of tgAAC94, Data Presented At 11th Annual American Society of Gene Therapy Meeting 6/2/2008
More...
|
Locus Pharmaceuticals, Inc. Initiates Strategic Inflammatory Cancer Research Collaborations 5/30/2008
More...
|
BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even BioElectronics Corporation President, CEO, and Chairman recaps recent investor conference call 5/22/2008
More...
|
Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas 5/22/2008
More...
|
Could Common Pain Killers Have A Role In Cancer Prevention? Data Presented At Digestive Disease Week 5/21/2008
More...
|
'Asbestos Warning' On Nanotubes, National Institute for Occupational Safety and Health Study 5/21/2008
More...
|
ChemoCentryx, Inc. Initiates Clinical Trial of CCR1 Inhibitor CCX354 Drug Represents Potential New Approach for the Treatment of Inflammatory Disease Milestone Triggers $10 Million Payment from Partner GlaxoSmithKline (GSK) 5/13/2008
More...
|
AlphaRx Inc. (ALRX)'s Indaflex(TM) Continues its Clinical Development 5/13/2008
More...
|
Aeolus Pharmaceuticals Inc. (AOLS.OB)' AEOL 10150 Protects Lungs from Fractionated Radiation; Reduces Angiogenesis and Inflammation 4/15/2008
More...
|
Regeneron Pharmaceuticals, Inc. (REGN)'s ARCALYST(TM), First and Only FDA-approved Treatment for Cryopyrin-Associated Periodic Syndromes, Now Available in the United States 3/25/2008
More...
|
FDA Calls Medtronic, Inc. (MDT) Drug Pump Warning Class I 3/20/2008
More...
|
University of Central Florida Researchers Discover A New Protein Family Implicated In Inflammatory Diseases 3/11/2008
More...
|
Amgen (AMGN) and Wyeth (WYE) New Findings Show Enbrel(R) (etanercept) Significantly Reduced Levels of C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate to Severe Plaque Psoriasis 2/1/2008
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Says Watson Pharmaceuticals, Inc. (WPI) to Sell Generic Anti-Inflammatory Drug; Salix Shares Sink 12/31/2007
More...
|
Rigel Pharmaceuticals, Inc. (RIGL) Announces Presentations at the 2007 American Society of Hematology Meeting 12/5/2007
More...
|
Prescient Medical Acquires New Technology To Detect Inflammation In Coronary Blood Vessels 11/19/2007
More...
|
ISTA Pharmaceuticals, Inc. (ISTA)'s Once-Daily Ocular Inflammation Drug Meets Goal 11/13/2007
More...
|
Targeted Genetics Corporation (TGEN) Announces Positive Interim Phase I/II Results for tgAAC94 in Inflammatory Arthritis
11/12/2007
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Says FDA Extends Priority Review of CAPS Treatment 11/2/2007
More...
|
CV Therapeutics, Inc. (CVTX) Data from Completed Phase 1 Studies of Novel Adenosine A2b Antagonist CVT-6883 Show Safety, Tolerability and Potential Utility in Chronic Pulmonary and Inflammatory Diseases 11/2/2007
More...
|
SCOLR Pharma, Inc. (DDD) Initiates Pivotal Trials for 12-hour Ibuprofen 11/1/2007
More...
|
Cytokine PharmaSciences Announces Oral Efficacy of Anti-Cytokine Semapimod 10/29/2007
More...
|
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate 10/25/2007
More...
|
Array BioPharma, Inc. (ARRY) (Jobs) and Celgene (CELG) (Jobs) in $40 Million Cancer, Inflammation Deal 9/24/2007
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Announces Filing of IND for Phase I/II Clinical Trials with HE3286 in Diseases of Inflammation 9/17/2007
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Reports on Anti-Inflammatory Activity with HE3286 in Models of Diseases of Inflammation 9/12/2007
More...
|
Pozen, Inc. (POZN) Receives $30M Payment from AstraZeneca PLC (AZN) 9/7/2007
More...
|
MD Biosciences Releases Mouse OVA-IgE ELISA 8/3/2007
More...
|
Novogen Limited (NVGN) Investigational Anti-Inflammatory Drug Produces Promising Results in Animal Studies 7/30/2007
More...
|
ChemoCentryx, Inc. Achieves $5 Million Milestone from GlaxoSmithKline (GSK) for Nomination of CCR1 Small Molecule Development Candidate 7/24/2007
More...
|
Neurochem, Inc. (NRMX) Receives Approvable Letter for Eprodisate (KIACTA(TM)) for Treatment of AA Amyloidosis; FDA Asks for More Data 7/18/2007
More...
|
University of Illinois Research Suggests Fitness May Reduce Inflammation 7/6/2007
More...
|
FDA Recommends Confirmatory Study for Vasogen (VSGN)'s Heart Treatment 6/27/2007
More...
|
Schering-Plough Corporation (SGP) and Centocor, Inc. (JNJ) REMICADE(R) Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation 6/15/2007
More...
|
Additional Data on CombinatoRx, Incorporated (CRXX) Drug Candidates CRx-102 and CRx-139 Presented at EULAR 6/14/2007
More...
|
Targeted Genetics Corporation (TGEN) Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference 6/14/2007
More...
|
Neurochem, Inc. (NRMX) Release: Landmark Study Published in The New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis 6/7/2007
More...
|
Anacor Pharmaceuticals, Inc. Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis 6/6/2007
More...
|
Fat Protein Protects Blood Vessels from Inflammation, May Help Heart Disease, Thomas Jefferson University Scientists Find 6/4/2007
More...
|
Targeted Genetics Corporation (TGEN) Reports Additional Data From Inflammatory Arthritis Clinical Trial 6/4/2007
More...
|
Targeted Genetics Corporation (TGEN) to Report Interim Data From a Phase I/II Clinical Trial of tgAAC94 in Patients With Inflammatory Arthritis and Highlight AAV Development Platform in 9 Additional Abstracts at ASGT Annual Meeting 5/30/2007
More...
|
Array BioPharma, Inc. (ARRY) to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on Inflammation 5/30/2007
More...
|
Targeted Genetics Corporation (TGEN) Completes Enrollment and Initial Dosing of tgAAC94 Phase I/II Trial in Patients With Inflammatory Arthritis 5/24/2007
More...
|
MedImmune, Inc. (MEDI) Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations 5/24/2007
More...
|
Alimentary Health New Data On the Probiotic Strain Bifantis(R) Shows Anti-Inflammatory Properties and Increased Health Benefits 5/21/2007
More...
|
Discovery Laboratories (DSCO)'s KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties 5/9/2007
More...
|
One of Life's Most Common Compounds Causes Allergic Inflammation, University of California, San Francisco (UCSF) (Jobs) Study Finds 4/23/2007
More...
|
Fatty Acid Tied to Depression and Inflammation, Ohio State University Study Finds 4/18/2007
More...
|
Omega-3 Fatty Acids Affect Risk of Depression, Inflammation, Ohio State University Study Finds 3/30/2007
More...
|
Gentium S.p.A. Release: Defibrotide Mechanism Of Action Data To Be Presented At Mechanisms Linking Cancer And Inflammation Symposium 2/12/2007
More...
|
Targeted Genetics Corporation (TGEN) Announces Publication Of Inflammatory Arthritis Study In Molecular Therapy 1/18/2007
More...
|
Evolutec Ltd To Stop Investing In rEV131 As Fails To Meet Trial Primary Endpoint 1/4/2007
More...
|
Imagenetix, Inc. (IAGX) Receives FDA Clearance To Begin Pre-IND Safety Studies On Anti-Inflammatory Compound 12/11/2006
More...
|
Akorn, Inc. (AKRN) Announces Tentative Approval Of Diclofenac Sodium Ophthalmic Solution 0.1% 11/30/2006
More...
|
ProtoKinetix Inc. (PKTX.OB)'s AAGP(TM) Significantly Reduces Inflammation 10/16/2006
More...
|
LAB International (CC:LAB) Reports Positive Results From Its LAB-CGRP Phase IIA Study 10/4/2006
More...
|
Amgen (AMGN) To Acquire Avidia, Inc., A Privately Held Biopharmaceutical Company In The San Francisco Bay Area; $290 Million Cash 9/29/2006
More...
|
Gene Transfer Using Mutant Form Of Good Cholesterol Cuts Vascular Plaque And Inflammation 9/29/2006
More...
|
Critical Therapeutics, Inc. (CRTX) Announces Results Of CTI-01 Phase II Trial; Drug Misses Goal 9/15/2006
More...
|
Anti-inflammatory Drugs Following Hip Replacement Surgery Could Harm Rather Than Help 9/11/2006
More...
|
Advanced Life Sciences (ADLS) Presents Scientific Data On The Synthesis And Apoptotic Activity Of New Caspase-Activating Pentacyclic Triterpenoids At The 232nd American Chemical Society National Meeting 9/11/2006
More...
|
Suncream That Can "Heal" Sunburn 9/8/2006
More...
|
Endovasc Inc. (EVSC) Announces Completion Of Liprostin Manufacturing For Phase IIIa Trial 9/6/2006
More...
|
MediciNova, Inc. Announces Completion Of Enrollment In A Phase II/III Interstitial Cystitis Trial With MN-001 9/5/2006
More...
|
Logical Therapeutics, Inc. In-Licenses Novel Anti-Inflammatory Drug 9/5/2006
More...
|
Depressed Patients Experience Excessive Inflammation During Stressful Situations 9/1/2006
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Announces Phase I Trial Of MLN0415 For Inflammatory Disorders 8/30/2006
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Announces U.S. Launch of Orapred ODT Through ALLIANT Pharmaceuticals, Inc. 8/28/2006
More...
|
GlaxoSmithKline (GSK) And ChemoCentryx, Inc. Enter Into $1.5 Billion Drug Discovery And Development Alliance In Inflammatory Disorders 8/24/2006
More...
|
Kemia, Inc. Announces Completion Of Phase I Trials For Oral Anti-Inflammatory Drug; KC706, A p38 MAP Kinase Inhibitor, Targets Inflammatory Conditions Including Arthritis, Psoriasis, And Cardiovascular Disease 8/23/2006
More...
|
Portfolio-Company, Revotar Biopharmaceuticals Concludes Start-Up Development Agreement With US Pharmaceuticals Manufacturer 8/22/2006
More...
|
Schering-Plough Corporation (SGP) Receives Clarification Of Its Rights For Golimumab; Market Rights Extended 8/18/2006
More...
|
Neurochem, Inc. (NRMX) Receives Approvable Letter For Eprodisate For Treatment Of AA Amyloidosis; FDA Asks For Additional Data Before Final Approval 8/14/2006
More...
|
Imagenetix, Inc. (IAGX) Appoints Former FDA, National Institutes of Health (NIH) Staffer To Guide IND Submission For Anti-Inflammatory Compound 6/26/2006
More...
|
Targeted Genetics Corporation (TGEN) Release: Interim Data On Use Of tgAAC94 In The Treatment Of Inflammatory Arthritis Presented At The European Rheumatology Meeting 6/22/2006
More...
|
Neurochem, Inc. (NRMX) Release: Eprodisate (Fibrillex(TM)) Data Presented At The Meeting Of The European League Against Rheumatism (EULAR) 6/22/2006
More...
|
VLST Corp. Raises $55 Million Series B Financing 6/16/2006
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Presents Positive Preclinical Data On Orally Active Anti-Inflammatory Steroids Developed For Treatment Of Lung Inflammation 6/16/2006
More...
|
Study Supports Potential Of Micromet's Human Antibody MT203 As Novel Anti-Inflammatory Treatment 6/15/2006
More...
|
CombinatoRx, Incorporated (CRXX) Reports Phase 2 Data On CRx-150 In Human Inflammatory Disease Model; Periodontitis Trial Fails Main Goal 6/7/2006
More...
|
Targeted Genetics Corporation (TGEN) Presents Encouraging Interim Data From An Ongoing Phase I/II Trial Of tgAAC94 In Patients With Inflammatory Arthritis 6/1/2006
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Receives Fast-Track Designation For The IL-1 Trap In CIAS1-Associated Periodic Syndromes (CAPS) 5/31/2006
More...
|
CollaGenex Pharmaceuticals, Inc. (CGPI) Receives FDA Approval For Oracea(TM) 5/30/2006
More...
|
TeGenero AG TGN 1412 Drug Trial Illnesses In UK Not Due To Errors 5/25/2006
More...
|
CombinatoRx, Incorporated (CRXX) Reports Second Positive Phase 2 Study With CRx-102; Achieved Primary Endpoint with Statistically Significant Reduction in C-Reactive Protein in Human Inflammatory Model 5/22/2006
More...
|
Imagenetix, Inc. (IAGX) Announces 1-Tetradecanol Complex Acts To Inhibit Bacteria And Enzymes Associated With Oral Disease, Sepsis And Inflammation 5/8/2006
More...
|
Inflammation Markers Identify Fatigue In Breast Cancer Survivors 5/1/2006
More...
|
Pine Bark Extract May Prevent Inflammation 4/27/2006
More...
|
More Fish Oil, Fewer Calories To Reduce Inflammation 4/20/2006
More...
|
Japan Tobacco And GlaxoSmithKline (GSK) Conclude Licensing Agreement For New Drug Candidate 4/20/2006
More...
|
Protein Differences May Explain Drug Reaction 3/20/2006
More...
|
Critical Therapeutics, Inc. (CRTX) Announces Decision To Discontinue Phase II Clinical Trial Of CTI-01 3/15/2006
More...
|
TeGenero AG's TGN 1412 Phase 1 Trial Goes Wrong In UK, Two Critically Ill 3/15/2006
More...
|
Resolvin E1 Protects Against Inflammation And Bone Loss 3/10/2006
More...
|
Zenyth Therapeutics (ZTL.AX) And MuriGen Therapeutics To Collaborate On New Drug 2/27/2006
More...
|
QLT Inc. (QLTI) Announces Preliminary Findings From Phase II Clinical Trial Of Lemuteporfin-Injectable In BPH; Shares Dip 3% On Results 2/14/2006
More...
|
Mouth Gel Curbs Oral Pain After Cancer Treatment 2/14/2006
More...
|
Taro Pharmaceutical Industries Ltd. (TARO) Receives Tentative Approval For Augmented Betamethasone Dipropionate Lotion ANDA 1/27/2006
More...
|
Chronic Inflammation Could Spur Cancer 1/24/2006
More...
|
Perrigo Company (PRGO) Announces FDA Approval For Desoximetasone Gel 1/11/2006
More...
|
AtheroGenics (AGIX) And AstraZeneca (AZN) Announce Late Stage License And Commercialization Agreement For Novel Atherosclerosis Drug AGI-1067; Deal Worth $1 Billion 12/22/2005
More...
|
Callisto Pharmaceuticals Establishes Guanilib As Developmental Name For Novel Drug Candidate For GI Disease 12/22/2005
More...
|
Molecular Pharmacology Limited (MLPH.OB) Begins Clinical Trial Of New Topical Compound For Pain And Inflammation 12/19/2005
More...
|
Pfizer Inc. (PFE) To Finance $100 Million Safety Study Of Celebrex 12/14/2005
More...
|
Proteo Biotech AG (PTEO.OB) And Proteo Inc. (PTEO.OB) Anti-Inflammatory Agent "Elafin" Has Been Successfully Tested In A Phase I Clinical Trial 12/13/2005
More...
|
Critical Therapeutics, Inc. (CRTX) Achieves Collaboration Milestone In HMGB1 Program; Demonstrates Efficacy Of HMGB1 Antibodies In Preclinical Models Of Inflammation 12/8/2005
More...
|
Virginia Commonwealth University Researchers Identify Structural Requirements Of Target Molecule For The Enzyme Linked To Inflammation In Humans 12/2/2005
More...
|
Apotex Receives Final Approval For Ofloxacin Otic 0.3% 11/30/2005
More...
|
Worm Eggs May Tackle Inflammation 11/28/2005
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) And Genentech, Inc. (DNA) Cancer Drug Helps Arthritis 11/14/2005
More...
|
CollaGenex Pharmaceuticals, Inc. (CGPI) Awarded $962,000 National Institutes of Health (NIH) Grant To Support Research Of Potent Anti-Inflammatory Effects Of Incyclinide (Col-3) 11/9/2005
More...
|
Aspirin May Help Prevent Throat Cancer 11/8/2005
More...
|
Merck & Co., Inc. (MRK) Conference Call And Audio Web Cast 11/3/2005
More...
|
NicOx SA (NCOX.F) And TOPIGEN Pharmaceuticals Inc. Sign Deal On Respiratory Drug 10/27/2005
More...
|
Javelin Pharmaceuticals (JVPH.OB) Announces Acceptance Of Marketing Authorization Application For European Regulatory Approval Of Dyloject(TM) 10/24/2005
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Announces U.S. FDA Acceptance Of Orapred ODT Filing 10/20/2005
More...
|
Pozen, Inc. (POZN) Hits $20 Million GlaxoSmithKline (GSK) Milestone 10/12/2005
More...
|
Cheeseburgers Are Good For The Gut 10/11/2005
More...
|
Scientists Pinpoint Inflammation Gene 10/10/2005
More...
|
Biovitrum AB Sharpens Strategic Focus, Increases Resources To Later Development Phases And Restructures Early Discovery; Layoffs May Be Necessary 10/6/2005
More...
|
Kemia, Inc. Announces Initiation Of Phase I Trials For Oral Anti-Inflammatory 10/6/2005
More...
|
Advitech (AVI.V) Announces Positive Results From Preclinical Study; New Potential Treatment For Inflammatory Bowel Diseases 10/6/2005
More...
|
Abbott Laboratories' (ABT) Humira Gets Additional OK For Psoriatic Arthritis 10/4/2005
More...
|
Delays Extend Prima Biomed (PRR.AX) And AstraZeneca (AZN) Partnership 9/27/2005
More...
|
First Link Found Between Obesity, Inflammation And Vascular Disease 9/19/2005
More...
|
On the Move? 9/9/2005
More...
|
Arakis Ltd. Commences Phase IIb Trial Ror RA Drug 9/6/2005
More...
|
Inotek Pharmaceuticals Corporation Raises $25 Million In First Tranche Of Series B Financing 8/30/2005
More...
|
Schering-Plough Corporation (SGP) To Develop Centocor, Inc. (JNJ) Compound 8/16/2005
More...
|
GTC Biotherapeutics (GTCB) Release: Recombinant Human Antithrombin Demonstrates Therapeutic Potential In Endotoxemia Model Of Sepsis 8/8/2005
More...
|
Law Firms Motley Rice LLC And Will Barristers Release: Morin & Miller Announce Class Action Lawsuit Against Merck Frosst Canada & Co., Merck Frosst Canada Ltd., And Merck & Co., Inc. (MRK) 8/8/2005
More...
|
Taro Pharmaceutical Industries Ltd. (TARO) Receives Approval For Hydrocortisone Butyrate Cream USP, 0.1% ANDA; Generic Equivalent To Locoid(R) Cream 8/4/2005
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Files New Drug Application For Orapred ODT 8/2/2005
More...
|
Positive Results Of CollaGenex Pharmaceuticals, Inc.'s (CGPI) Phase 2 Clinical Study Evaluating Effects Of COL-3 For Treating Rosacea Presented At North Carolina Dermatology Association 8/2/2005
More...
|
Quigley Corporation (QGLY) Announces Positive In-Vitro Study Results Of Its QR440 Compound Support Conclusions Of Previous Animal Study Findings 8/1/2005
More...
|
Targeted Genetics Corporation (TGEN) Announces Preliminary Results Of Phase I Clinical Trial Of tgAAC94 In Patients With Inflammatory Arthritis 7/26/2005
More...
|
Scientists At Galileo Pharmaceuticals, Inc. Confirm Inflammatory Response Linked To Glucose Levels 7/22/2005
More...
|
Cellular Genomics, Inc. Selects Drug Development Candidate In Proprietary Angiogenesis Inhibitor Program; Changes Corporate Name To CGI Pharmaceuticals 7/13/2005
More...
|
Study Highlights Pycnogenol's Anti-Swelling Action 7/11/2005
More...
|
Pharmos Corporation (PARS) To Initiate Clinical Program In Tissue-Directed Treatment Of Inflammation And Pain 7/6/2005
More...
|
Vasogen (VSGN) Announces Successful Results From Phase I Clinical Trial Of VP025 7/5/2005
More...
|
Helix BioMedix, Inc. (HXBM) Antimicrobial Peptides Show Promise In Reducing Lung Infection And Inflammation Resulting From Cystic Fibrosis 7/5/2005
More...
|
AtheroGenics (AGIX) Schedules Conclusion Of Patient Screening In Pivotal Phase III ARISE Trial 6/30/2005
More...
|
The Quigley Corporation Announces Results Of Animal Model Inflammation Studies Of Its QR440 Botanical, Anti-Inflammatory Compound 6/28/2005
More...
|
Scientists Report RegeneRx Biopharmaceuticals's (RGRX) TB4 Decreases Inflammation And Restores Corneal Clarity After Eye Injury 6/28/2005
More...
|
Global Pharmatech Successfully Licenses Another New Drug 6/28/2005
More...
|
Corgentech, Inc. (CGTK) Presents Preclinical Data Demonstrating Reduction Of Inflammation Using New Drug Candidate For Inflammatory Bowel Disease 6/27/2005
More...
|
WellGen, Inc. Announces Renewed And Expanded Research Contract And Licensing Agreement With Rutgers University 6/27/2005
More...
|
Novartis AG (NVS) Release: FTY720, A Novel Once-Daily Oral Medication, Shows Promising Results In Treatment Of Multiple Sclerosis; But Phase III Delayed 6/21/2005
More...
|
ProMetic Life Sciences Inc. (PFSCF.PK) Announces Closing Of $15 Million Financing 6/17/2005
More...
|
Revotar Biopharmaceuticals Granted Orphan Drug Designation By The European Medicines Agency For Bimosiamose Disodium To Treat Patients Suffering From Acute Lung Injury 6/17/2005
More...
|
Phytomedics, Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property From Louisiana State University System 6/16/2005
More...
|
Common Painkillers Raise Heart-Attack Risk, Study Indicates 6/10/2005
More...
|
Enzo Biochem (ENZ) Acquires Rights To Orphan Drug Candidate For Treating Uveitis, Chronic Inflammation Of The Eye 6/10/2005
More...
|
Abbott Laboratories' (ABT) HUMIRA(R) (Adalimumab) Shown To Improve Quality Of Life For Psoriatic Arthritis Patients 6/10/2005
More...
|
Bristol-Myers Squibb Company (BMY) Release: New Phase III Efficacy Data On Investigational Biologic Abatacept Presented At European League Against Rheumatism Meeting 6/9/2005
More...
|
Chelsea Therapeutics, Inc. Initiates Phase I Clinical Trial Of CH-1504 6/9/2005
More...
|
Biovation Closes Down By Its Parent, The Pharmaceutical Giant Merck 6/8/2005
More...
|
AnGes MG Inc., And MedGel To Jointly Explore Feasibility Of New Anti-inflammatory Agent Using NF-kappa B Decoy Oligo 6/8/2005
More...
|
CollaGenex Pharmaceuticals, Inc. (CGPI) Announces Agreement With Primus Pharmaceuticals, Inc. To Promote Alcortin And Novacort To Dermatologists 6/8/2005
More...
|
Chelsea Therapeutics, Inc. Granted Approval From UK Health Authority To Begin Phase I Clinical Trials For CH-1504 6/7/2005
More...
|
McNeil Consumer & Specialty Pharmaceuticals (JNJ) Announces Nationwide Recall Of Children's TYLENOL(R) Meltaways - 80 mg, Children's TYLENOL(R) SoftChews - 80 mg And Jr. TYLENOL(R) Meltaways - 160 mg 6/3/2005
More...
|
Exelixis, Inc. (EXEL) And Genentech, Inc. (DNA) Collaborate On Novel Therapeutics For Cancer, Inflammation, And Tissue Growth And Repair 6/3/2005
More...
|
Biovitrum AB Starts Collaboration With Karolinska Institute In Inflammation Research 5/31/2005
More...
|
Strong Genetic Basis For Tonsillitis 5/26/2005
More...
|
MediciNova, Inc. Initiates A Phase II Clinical Trial With MN-001 In Interstitial Cystitis 5/24/2005
More...
|
Otsuka America Pharmaceutical, Inc. Release: Multiple Studies At Digestive Disease Week Report On Adacolumn(R) Apheresis Device In Treating Inflammatory Bowel Disease 5/18/2005
More...
|
GenPat77 AG's Novel Approach To Immune Disorder Therapy Supported By Presentations At Medical Conferences 5/17/2005
More...
|
Obesity-Linked Lung Stress May Trigger Asthma 5/13/2005
More...
|
Prometheus Laboratories Inc. Announces FDA Approval For Additional Indication Of Entocort(R) EC (budesonide) Capsules 5/10/2005
More...
|
Medarex, Inc. (MEDX) Announces Upcoming Presentations At American Society of Clinical Oncology Meeting 5/9/2005
More...
|
Corgentech, Inc. (CGTK) Presents Preclinical Data Demonstrating Reduction Of Inflammation Using New Drug Candidate For Eczema 5/9/2005
More...
|
Reata Announces RTA 744 Entering Clinical Development; Name Changed To Reata Pharmaceuticals, Inc. 5/6/2005
More...
|
Synta Pharmaceuticals Postpones Initial Public Offering 5/3/2005
More...
|
Serono, Inc. (SRA) And Genmab A/S (GNMSF.PK) Sign Worldwide Agreement To Develop And Commercialize HuMax-TAC; Up To USD 38 Million 5/2/2005
More...
|
AVANIR Pharmaceuticals (AVN) Announces Worldwide Collaboration With Novartis (NVS) On The Development Of Novel Therapeutics For Inflammation 4/28/2005
More...
|
Advanced Life Sciences Files For $86 Millon IPO 4/28/2005
More...
|
MorphoSys AG Provides Update On MOR102 Program In Psoriasis 4/28/2005
More...
|